Caricamento...

Results of a phase I, open-label, randomized, crossover study evaluating the effects of linifanib on QTc intervals in patients with solid tumors

PURPOSE: Linifanib is a selective inhibitor of the vascular endothelial growth factor and platelet-derived growth factor family of tyrosine kinase inhibitors. The purpose of this high-precision QT study was to evaluate the effects of linifanib on cardiac repolarization in patients with advanced meta...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Chiu, Yi-Lin, LoRusso, Patricia, Hosmane, Balakrishna, Ricker, Justin L., Awni, Walid, Carlson, Dawn M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer Berlin Heidelberg 2013
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3889813/
https://ncbi.nlm.nih.gov/pubmed/24241212
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-013-2351-2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !